EXHIBIT 10.1
SECURITIES PURCHASE AGREEMENT
This Securities Purchaser Agreement (the "Agreement") is made as of
March 12, 2002 by and between _________________ ("Purchaser"), and
NeoTherapeutics, Inc. ("Company"), whereby the parties agree as follows:
The Purchaser shall buy from the Company and the Company agrees to sell
to the Purchaser: (i) _______ shares (the "Shares") of the Company's common
stock, par value $.001 per share (the "Common Stock"), at a price of $2.00 per
share for an aggregate purchase price of $_________ (the "Purchase Price"), and
(ii) a five-year warrant to purchase up to __________ shares of Common Stock
(the "Warrant"), at an exercise price of $2.75 per share, in the form attached
hereto as Exhibit A.
---------
The Shares and the Warrant are being issued and sold pursuant to a
registration statement on Form S-3, File No. 333-53108, which registration
statement has been declared effective by the Securities and Exchange Commission.
The Company is delivering herewith a prospectus supplement on Form 424(b)(5)
regarding the issuance and sale of the Shares and the Warrant prior to funding,
a copy of which is attached hereto as Exhibit B. The Shares and Warrant are free
---------
of restrictive legends and the Shares and the shares of Common Stock issuable
upon exercise of the Warrant, when issued upon exercise of the Warrant in
accordance with its terms and as described in the prospectus supplement, will be
free of any resale restrictions.
Prior to the close of business on the date hereof:
1. The Purchaser shall wire the Purchase Price to the Company to the
account set forth below.
Company Wire Transfer Instructions:
Chase Manhattan Bank
1 Chase Plaza
New York, NY 10004
ABA # 021 000 021
FBO Salomon Smith Barney
A/C # 066-198038
For Further Credit to:
Neotherapeutics, Inc.
A/C # 561-04051-19-103
2. The Company shall (A) deliver a facsimile copy of the Warrant to
the Purchaser at the address for notices set forth below, with the
original Warrant to be delivered to such address on the next
following business day,and (B) cause its transfer agent to transmit
the Shares electronically to the Purchaser by crediting the account
set forth below through the Deposit Withdrawal Agent Commission
system.
Purchaser DWAC Instructions:
DTC No.:
---------------------------------
Account No.:
-----------------------------
Reference:
-------------------------------
Notices to the Company shall be delivered to:
NeoTherapeutics, Inc.
Attention: Samuel Gulko
Senior Vice President Finance, Chief Financial Officer, Secretary
and Treasurer
157 Technology Drive,
Irvine, California 92618
Facsimile: (949) 788-6706
Notices to Purchaser shall be delivered to:
Purchaser Name:
--------------------------
Attn:
------------------------------------
Address:
---------------------------------
-----------------------------------------
Facsimile:
-------------------------------
Delivery of an executed copy of a signature page to this Agreement by
facsimile transmission shall be effective as delivery of a manually executed
copy of this Agreement and shall be effective and enforceable as the original.
This Agreement may be executed in one or more counterparts, each of which shall
be deemed an original, but all of which together shall constitute one and the
same instrument. This Agreement shall be governed and construed in accordance
with the internal laws of the State of California without giving effect to the
conflicts of law principles thereunder.
AGREED AND ACCEPTED, as of the date indicated above:
NeoTherapeutics, Inc.
By:
----------------------------------
Name:
--------------------------------
Title:
-------------------------------
Purchaser Name:
--------------------
By:
----------------------------------
Name:
--------------------------------
Title:
-------------------------------